Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Institutional investors would be good
View:
Post by Transperance on Jun 13, 2022 1:10pm

Institutional investors would be good

Good to see that the company is in The Market Herald. 
 
It would be good for the company and for us shareholders if some institutional investors and fund managers invests in SBM.
 
I have already given info to some managers in my home country, but the opportunities must be much larger in Canada where the company is listed. 
Comment by MirrorWorldMan on Jun 13, 2022 1:17pm
No money manager will touch this without numbers
Comment by Pareto8020 on Jun 13, 2022 2:10pm
Yep - they really should have waited and included the numbers for the deal.  Hence the tepid reception of the "blockbuster" news.   Fingers crossed the upfront is a decent amount and the royalties are in SBM's favour not AbbieVie.
Comment by MirrorWorldMan on Jun 13, 2022 2:21pm
They should of requested a halt to trading and prepare clear transparent details. Twits
Comment by Transperance on Jun 13, 2022 2:48pm
Don´t know if they halted the trading in Europe, don´t think so by the look of the intraday chart, but the timing of the news release was not adequate. The NR came before the market opened in Canada alright but it was in the middle of the trading day in Europe. 
Sirona Biochem Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities